Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP630935.RAoClj_dSxGpI47Z5B6cbdAM1u1AmIxQ7ZRZ-JhGlQ60g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP630935.RAoClj_dSxGpI47Z5B6cbdAM1u1AmIxQ7ZRZ-JhGlQ60g130_assertion type Assertion NP630935.RAoClj_dSxGpI47Z5B6cbdAM1u1AmIxQ7ZRZ-JhGlQ60g130_head.
- NP630935.RAoClj_dSxGpI47Z5B6cbdAM1u1AmIxQ7ZRZ-JhGlQ60g130_assertion description "[Competitive ELISAs for measuring total BSP, DSPP, MEPE, and OPN were applied to a test group of 102 subjects with prostate cancer and 110 normal subjects and a validation group of 90 subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630935.RAoClj_dSxGpI47Z5B6cbdAM1u1AmIxQ7ZRZ-JhGlQ60g130_provenance.
- NP630935.RAoClj_dSxGpI47Z5B6cbdAM1u1AmIxQ7ZRZ-JhGlQ60g130_assertion evidence source_evidence_literature NP630935.RAoClj_dSxGpI47Z5B6cbdAM1u1AmIxQ7ZRZ-JhGlQ60g130_provenance.
- NP630935.RAoClj_dSxGpI47Z5B6cbdAM1u1AmIxQ7ZRZ-JhGlQ60g130_assertion SIO_000772 19671866 NP630935.RAoClj_dSxGpI47Z5B6cbdAM1u1AmIxQ7ZRZ-JhGlQ60g130_provenance.
- NP630935.RAoClj_dSxGpI47Z5B6cbdAM1u1AmIxQ7ZRZ-JhGlQ60g130_assertion wasDerivedFrom befree-20140225 NP630935.RAoClj_dSxGpI47Z5B6cbdAM1u1AmIxQ7ZRZ-JhGlQ60g130_provenance.
- NP630935.RAoClj_dSxGpI47Z5B6cbdAM1u1AmIxQ7ZRZ-JhGlQ60g130_assertion wasGeneratedBy ECO_0000203 NP630935.RAoClj_dSxGpI47Z5B6cbdAM1u1AmIxQ7ZRZ-JhGlQ60g130_provenance.